Related Experiment Video

Updated: Aug 26, 2026

Isolation of Neonatal Extrahepatic Cholangiocytes
07:54

Isolation of Neonatal Extrahepatic Cholangiocytes

Published on: June 5, 2014

Neonatal hepatitis syndrome

Eve A Roberts1

  • 1Division of Gastroenterology and Nutrition, Room 8267, Black Wing, The Hospital for Sick Children, Toronto, Ontario, Canada. eve.roberts@sickkids.ca

Seminars in Neonatology : SN
|March 6, 2004
PubMed

Insights

Elevated conjugated bilirubin in infants signals neonatal liver disease, requiring prompt diagnosis and treatment for optimal outcomes. Early intervention, especially for biliary atresia, significantly improves prognosis.

Area of Science:

  • Neonatology
  • Pediatric Gastroenterology
  • Hepatology

Background:

  • Conjugated hyperbilirubinaemia in infants is a key indicator of neonatal liver disease, specifically neonatal hepatitis syndrome.
  • Numerous potential etiologies exist, encompassing infective, structural, metabolic, genetic, neoplastic, vascular, toxic, immune, and idiopathic causes.

Purpose of the Study:

  • To emphasize the critical need for measuring serum conjugated bilirubin in jaundiced infants aged 2-4 weeks.
  • To highlight the importance of a systematic diagnostic approach upon detecting conjugated hyperbilirubinaemia.
  • To underscore the urgency of early diagnosis and treatment for improved patient outcomes.

Main Methods:

  • Measurement of serum conjugated bilirubin in jaundiced infants.
  • Comprehensive diagnostic investigation for identified conjugated hyperbilirubinaemia.
  • Timely initiation of specific treatments based on diagnosis.

Main Results:

  • Early diagnosis of neonatal liver disease is crucial for effective management.
  • Palliative surgery for extrahepatic biliary atresia shows highest success rates before 8 weeks of age.
  • Prompt initiation of definitive treatments or liver transplantation can be life-saving.

Conclusions:

  • All jaundiced infants require conjugated bilirubin assessment, regardless of apparent well-being.
  • A methodical diagnostic workup is essential for conjugated hyperbilirubinaemia.
  • Early and appropriate interventions, including supportive nutritional care, are vital for managing neonatal hepatitis syndrome.

Related Concept Videos

Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...